| Long name: |
FITC Conjugated, ADAM17 Polyclonal Antibody |
| Category: |
Conjugated Primary Antibodies |
| Conjugation: |
Anti-FITC Antibody |
| Host Organism: |
Rabbit (Oryctolagus cuniculus) |
| Target Antigen: |
ADAM17 |
| Specificity: |
This is a highly specific antibody against ADAM17 |
| Modification: |
Unmodified |
| Modification site: |
None |
| Clonality: |
Polyclonal |
| Clone: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Immunogen_range: |
216-266/824 |
| Subcellular location: |
Extracellular |
| Source: |
KLH conjugated synthetic peptide derived from human ADAM17 |
| Gene ID number: |
6868 |
| Swiss Prot: |
P78536 |
| Tested applications: |
IF(IHC-P), FCM |
| Recommended dilutions: |
IF(IHC-P)(1:50-200), FCM(1:20-100) |
| Crossreactivity: |
Mouse, Rat, Human |
| Crossreactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Antigen background: |
Acts as an activator of Notch pathway by mediating cleavage of Notch, L-selectin, MUC1 and the amyloid precursor protein, Plays a role in the proteolytic processing of ACE2, Responsible for the proteolytic release of several other cell-surface proteins, Responsible for the proteolytical release of soluble JAM3 from endothelial cells surface, generating the membrane-associated intermediate fragment called Notch extracellular truncation (NEXT), growth hormone receptor, including p75 TNF-receptor, interleukin 1 receptor type II, p55 TNF-receptor, transforming growth factor-alpha, Cleaves the membrane-bound precursor of TNF-alpha to its mature soluble form |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA |
| Excitation Emission: |
494nm/518nm |
| Synonyms: |
cSVP CD156B |
| Properties: |
Bioss Primary Conjugated Antibodies FITC is highly sensitive to pH extremes, FITC has a green emission that's usually collected at 530 nanometers, FITC has a high quantum yield (efficiency of energy transfer from absorption to emission fluorescence) and approximately half of the absorbed photons are emitted as fluorescent light, For fluorescent microscopy applications, This Bioss Primary Conjugated Antibodies Fluorescein isothiocyanate (FITC) antibody is currently after some BD antibodies the most commonly used fluorescent dye for FACS, When excited at 488 nanometers, its photo bleaching effects are not observed due to a very brief interaction at the laser intercept, the 1 FITC is seldom used as it photo bleaches rather quickly though in flow cytometry applications, the FL1 detector of a FACSCalibur or FACScan, C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
ADAM17 Conjugated |
| Short name: |
FITC Conjugated, ADAM17 Antibody |
| Technique: |
Fluorescein, antibodies against human proteins, antibodies for, antibody Conjugates, Antibody |
| Label: |
FITC |
| Alternative name: |
fluorecein coupled, ADAM metallopeptidase domain 17 (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
ADAM17 and IDBG-27788 and ENSG00000151694 and 6868, ADAM17 and IDBG-638333 and ENSBTAG00000001141 and 517541, ADAM18 and CD156B and CSVP and NISBD and TACE, Adam17 and IDBG-130508 and ENSMUSG00000052593 and 11491, Cell surfaces, PDZ domain binding, spreading of epidermal cells and biological process this GO :0035625 and epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway and biological process this GO :0042493 and response to drug and biological process this GO :0045121 and membrane raft and cellular component this GO :0045741 and positive regulation of epidermal growth factor-activated receptor activity and biological process this GO :0048011 and neurotrophin TRK receptor signaling pathway and biological process this GO :0048536 and spleen development and biological process this GO :0048870 and cell motility and biological process this GO :0051088 and PMA-inducible membrane protein ectodomain proteolysis and biological process this GO :0051272 and positive regulation of cellular component movement and biological process this GO :0055099 and response to high density lipoprotein particle stimulus and biological process this GO :0060397 and JAK-STAT cascade involved in growth hormone signaling pathway and biological process this GO :0097190 and apoptotic signaling pathway and biological process, this GO :0001666 and response to hypoxia and biological process this GO :0001934 and positive regulation of protein phosphorylation and biological process this GO :0002446 and neutrophil mediated immunity and biological process this GO :0002467 and germinal center formation and biological process this GO :0002690 and positive regulation of leukocyte chemotaxis and biological process this GO :0004222 and metalloendopeptidase activity and molecular function this GO :0005112 and Notch binding and molecular function this GO :0005138 and interleukin-6 receptor binding and molecular function this GO :0005178 and integrin binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005737 and cytoplasm and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0005887 and integral component of plasma membrane and cellular component this GO :0005911 and cell-cell junction and cellular component this GO :0005925 and focal adhesion and cellular component this GO :0006508 and proteolysis and biological process this GO :0006509 and membrane protein ectodomain proteolysis and biological process this GO :0006915 and apoptotic process and biological process this GO :0007155 and cell adhesion and biological process this GO :0007173 and epidermal growth factor receptor signaling pathway and biological process this GO :0007219 and Notch signaling pathway and biological process this GO :0007220 and Notch receptor processing and biological process this GO :0008237 and metallopeptidase activity and molecular function this GO :0008270 and zinc ion binding and molecular function this GO :0008284 and positive regulation of cell proliferation and biological process this GO :0009986 and cell surface and cellular component this GO :0010820 and positive regulation of T cell chemotaxis and biological process this GO :0015629 and actin cytoskeleton and cellular component this GO :0016020 and membrane and cellular component this GO :0016324 and apical plasma membrane and cellular component this GO :0017124 and SH3 domain binding and molecular function this GO :0022617 and extracellular matrix disassembly and biological process this GO :0030165 and PDZ domain binding and molecular function this GO :0030183 and B cell differentiation and biological process this GO :0030198 and extracellular matrix organization and biological process this GO :0030307 and positive regulation of cell growth and biological process this GO :0030335 and positive regulation of cell migration and biological process this GO :0030511 and positive regulation of transforming growth factor beta receptor signaling pathway and biological process this GO :0030512 and negative regulation of transforming growth factor beta receptor signaling pathway and biological process this GO :0030574 and collagen catabolic process and biological process this GO :0031293 and membrane protein intracellular domain proteolysis and biological process this GO :0031659 and positive regulation of cyclin-dependent protein kinase activity involved in G1/S and biological process this GO :0032496 and response to lipopolysaccharide and biological process this GO :0032587 and ruffle membrane and cellular component this GO :0032717 and negative regulation of interleukin-8 production and biological process this GO :0032722 and positive regulation of chemokine production and biological process this GO :0033025 and regulation of mast cell apoptotic process and biological process this GO :0033077 and T cell differentiation in thymus and biological process this GO :0033627 and cell adhesion mediated by integrin and biological process this GO :0035313 and wound healing, this GO :0004222 : metalloendopeptidase activity, this GO :0004222 : metalloendopeptidase activity and also this GO :0005112 : Notch binding and also this GO :0005138 : interleukin-6 receptor binding and also this GO :0005178 : integrin binding and also this GO :0005515 : protein binding and also this GO :0008237 : metallopeptidase activity and also this GO :0008270 : zinc ion binding and also this GO :0017124 : SH3 domain binding and also this GO :0030165 : PDZ domain binding, this GO :0005112 : Notch binding, this GO :0005138 : interleukin-6 receptor binding, this GO :0005178 : integrin binding, this GO :0005515 : protein binding, this GO :0008237 : metallopeptidase activity, this GO :0008270 : zinc ion binding, this GO :0017124 : SH3 domain binding, this GO :0030165 : PDZ domain binding, ADAM metallopeptidase domain 17 |
| Identity: |
195 |
| Gene: |
ADAM17 |
More about : ADAM17 |
| Long gene name: |
ADAM metallopeptidase domain 17 |
| Synonyms gene: |
TACE |
| Synonyms gene name: |
alpha, converting enzyme , tumor necrosis factor |
| Locus: |
2p25, 1 |
| Discovery year: |
1997-04-10 |
| GenBank acession: |
U69611 |
| Entrez gene record: |
6868 |
| Pubmed identfication: |
9034190 9574564 |
| Classification: |
ADAM metallopeptidase domain containing CD molecules |
| Havana BLAST/BLAT: |
OTTHUMG00000090425 |